Loading financials from SEC filings…
Chemicals · Basic Materials · Fiscal year ends Mar 28
Hawkins reported revenue of $1.1B in the fiscal year ended Mar 2026, up 11.2% from the year before. Operating income was $121M, an operating margin of 11.2%, and net income was $82M. Operating cash flow of $144M less capital expenditure of $58M left free cash flow of $86M. Net debt was $240M.
Ranks among the 18 chemicals companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Apr 2022 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 775 | 935 | 919 | 974 | 1,084 |
| Cost of revenue | 628 | 770 | 726 | 749 | 839 |
| Gross profit | 147 | 165 | 194 | 226 | 245 |
| Selling, general & admin | 75.3 | 77.0 | 89.6 | 106 | 124 |
| Operating income | 71.2 | 88.2 | 104 | 119 | 121 |
| Net interest incomeBanks | −1.4 | −5.2 | −4.3 | −5.4 | −13.5 |
| Pre-tax income | 70.0 | 82.6 | 101 | 114 | 109 |
| Income tax | 18.4 | 22.5 | 25.8 | 30.0 | 27.8 |
| Net income | 51.5 | 60.0 | 75.4 | 84.3 | 81.5 |
| Diluted EPS | 2.44 | 2.86 | 3.59 | 4.03 | 3.91 |
| Diluted shares | 21.1 | 21.0 | 21.0 | 20.9 | 20.9 |
| Fiscal year | Apr 2022 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 3.5 | 7.6 | 7.2 | 5.1 | 3.9 |
| Receivables | 123 | 129 | 114 | 132 | 140 |
| Inventory | 95.0 | 88.8 | 74.6 | 83.5 | 78.2 |
| Current assets | 228 | 232 | 203 | 231 | 231 |
| Net PP&E | 162 | 186 | 209 | 225 | 266 |
| Goodwill | 77.4 | 77.4 | 103 | 135 | 223 |
| Total assets | 567 | 591 | 658 | 770 | 986 |
| Payables | 66.7 | 53.7 | 56.4 | 61.2 | 59.8 |
| Deferred revenue | – | – | – | 0.0 | 1.6 |
| Current liabilities | 101 | 90.9 | 103 | 97.2 | 105 |
| Short-term debt | 9.9 | 9.9 | 9.9 | 9.9 | – |
| Long-term debt | 116 | 102 | 88.8 | 149 | 244 |
| Total liabilities | 265 | 241 | 252 | 310 | 452 |
| Shareholders' equity | 303 | 350 | 406 | 460 | 534 |
| Fiscal year | Apr 2022 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating cash flow | 42.8 | 77.4 | 159 | 111 | 144 |
| Capital expenditure | 28.5 | 48.3 | 40.2 | 41.1 | 58.2 |
| Free cash flow | 14.3 | 29.1 | 119 | 70.0 | 86.1 |
| Depreciation & amortisation | 24.1 | 27.4 | 31.8 | 39.9 | 52.5 |
| Stock-based compensation | 3.8 | 3.8 | 4.9 | 6.5 | 8.6 |
| Acquisitions | 21.5 | 0.0 | 83.5 | 87.4 | 167 |
| Dividends paid | 11.1 | 12.0 | 13.2 | 14.6 | 15.7 |
| Dividend per share | 0.52 | 0.57 | 0.63 | 0.70 | 0.75 |
| Fiscal year | Apr 2022 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 20.7% | −1.7% | 6.0% | 11.2% |
| Operating income growth (YoY) | – | 23.8% | 18.0% | 14.6% | 1.8% |
| EPS growth (YoY) | – | 17.2% | 25.5% | 12.3% | −3.0% |
| Gross margin | 18.9% | 17.7% | 21.1% | 23.1% | 22.6% |
| Operating margin | 9.2% | 9.4% | 11.3% | 12.2% | 11.2% |
| Net margin | 6.7% | 6.4% | 8.2% | 8.7% | 7.5% |
| Return on equityBlank when equity is negative | 17.0% | 17.2% | 18.6% | 18.3% | 15.3% |
| ROCEEBIT ÷ (assets − current liabilities) | 15.3% | 17.6% | 18.8% | 17.7% | 13.8% |
| Free cash flow margin | 1.8% | 3.1% | 13.0% | 7.2% | 7.9% |
| Cash conversion (CFO ÷ net income) | 0.83x | 1.29x | 2.12x | 1.32x | 1.77x |
| Receivable days | 58 | 50 | 45 | 49 | 47 |
| Inventory days | 55 | 42 | 38 | 41 | 34 |
| Payable days | 39 | 25 | 28 | 30 | 26 |
| Debt ÷ equity | 0.41x | 0.32x | 0.24x | 0.35x | 0.46x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 122 | 104 | 91.6 | 154 | 240 |
| Current ratio | 2.24x | 2.55x | 1.96x | 2.37x | 2.21x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.